Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 136.82 M146.79 M174.9 M141.37 M128.83 M 591.9 M Research & development 75.13 M79.38 M73.81 M73.18 M66.09 M 292.46 M Operating income -43.9 M-49.46 M-69.99 M-33.98 M-15.24 M -168.67 M Non-Operating Income, Total 5.83 M3.31 M3.61 M3.57 M2.9 M 13.38 M Interest expense, net of interest capitalized 791 K797 K767 K793 K649 K 3.01 M Non-Operating Income, excl. Interest Expenses 3.47 M3.04 M4.53 M3.42 M3.86 M 14.85 M Unusual income/expense 2.36 M267 K-921 K143 K-957 K -1.47 M Pretax income -38.87 M-46.95 M-67.14 M-31.21 M-12.99 M -158.29 M Equity in earnings ————— — Taxes 1.15 M1.41 M1.29 M1 M1.42 M 5.12 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -40.02 M-48.36 M-68.43 M-32.21 M-14.4 M -163.41 M Discontinued operations ————— — Net income -40.02 M-48.36 M-68.43 M-32.21 M-14.4 M -163.41 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -40.02 M-48.36 M-68.43 M-32.21 M-14.4 M -163.41 M Basic earnings per share (Basic EPS) -0.17-0.2-0.29-0.14-0.06 -0.69 Diluted earnings per share (Diluted EPS) -0.17-0.2-0.29-0.14-0.06 -0.69 Average basic shares outstanding 234.86 M236.22 M237.79 M236.82 M238.16 M — Diluted shares outstanding 234.86 M236.22 M237.79 M236.82 M238.16 M — EBITDA -39 M-44.26 M-64.19 M-27.89 M-9.14 M -145.47 M EBIT -43.9 M-49.46 M-69.99 M-33.98 M-15.24 M -168.67 M Cost of revenue 19.23 M20.22 M22.31 M25 M25.41 M 92.95 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 4.9 M5.2 M5.8 M6.1 M6.1 M 23.2 M